Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FJ5JZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $104,687
Award facts
- Contract value 100% obligated
- $104,687.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $104,687.30 on September 26, 2025, for the supply of XGEVA 120 mg/1.7 mL vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 29, 2025, and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through open competition without any set-aside designation. As a critical federal vendor for military and veteran healthcare systems, the company demonstrates significant capability in fulfilling federal medical supply needs across multiple therapeutic domains. This award reflects AmerisourceBergen's established role as a primary pharmaceutical supplier for the Defense Health Agency and other government healthcare systems, with a demonstrated track record of delivering diverse medical commodities ranging from specialty medications to brand-name and generic drugs supporting military health operations globally.
Quick answers
Who was awarded contract SPE2DB25FJ5JZ?
SPE2DB25FJ5JZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FJ5JZ worth?
The government has obligated $104,687 on SPE2DB25FJ5JZ.
Is contract SPE2DB25FJ5JZ an order under another contract?
Yes. SPE2DB25FJ5JZ is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5JZ competed?
The extent of competition for SPE2DB25FJ5JZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award